Dan Kong

666 total citations
34 papers, 538 citations indexed

About

Dan Kong is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Dan Kong has authored 34 papers receiving a total of 538 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 8 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Dan Kong's work include Renal Diseases and Glomerulopathies (6 papers), MicroRNA in disease regulation (4 papers) and Cancer-related molecular mechanisms research (4 papers). Dan Kong is often cited by papers focused on Renal Diseases and Glomerulopathies (6 papers), MicroRNA in disease regulation (4 papers) and Cancer-related molecular mechanisms research (4 papers). Dan Kong collaborates with scholars based in China, Japan and United States. Dan Kong's co-authors include Xiaoming Jin, Tianzhen Wang, Jianjun Jiang, Weidong Hao, Ran Liu, Masanobu Oshima, Boryana Konstantinova Popivanova, K. Oguma, Tomo‐o Ishikawa and Yang Li and has published in prestigious journals such as Carbohydrate Polymers, Journal of Cellular Physiology and Medicine.

In The Last Decade

Dan Kong

31 papers receiving 530 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dan Kong China 14 306 181 81 78 59 34 538
Dikaia Xenaki Australia 14 326 1.1× 132 0.7× 81 1.0× 73 0.9× 34 0.6× 33 678
Alexandre Coutant France 8 311 1.0× 87 0.5× 66 0.8× 66 0.8× 51 0.9× 8 521
Peihong Zhou United States 11 209 0.7× 76 0.4× 95 1.2× 86 1.1× 24 0.4× 28 740
Junyong Han China 14 300 1.0× 111 0.6× 61 0.8× 109 1.4× 53 0.9× 29 570
Manar Atyah China 13 287 0.9× 204 1.1× 42 0.5× 135 1.7× 22 0.4× 27 543
Wang Wl China 11 217 0.7× 108 0.6× 103 1.3× 96 1.2× 14 0.2× 44 475
Barbara Sato United States 12 364 1.2× 92 0.5× 47 0.6× 59 0.8× 54 0.9× 17 589
Qiong Shi China 12 273 0.9× 135 0.7× 27 0.3× 198 2.5× 29 0.5× 20 584
Siyuan Yan China 15 366 1.2× 184 1.0× 135 1.7× 99 1.3× 10 0.2× 33 606

Countries citing papers authored by Dan Kong

Since Specialization
Citations

This map shows the geographic impact of Dan Kong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Kong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Kong more than expected).

Fields of papers citing papers by Dan Kong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan Kong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Kong. The network helps show where Dan Kong may publish in the future.

Co-authorship network of co-authors of Dan Kong

This figure shows the co-authorship network connecting the top 25 collaborators of Dan Kong. A scholar is included among the top collaborators of Dan Kong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan Kong. Dan Kong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Jing, Zhaoying Li, Jing Wang, et al.. (2025). LncBADR promotes T cell-mediated autoimmunity by binding Mccc1 and Pcca to regulate BCAAs degradation. Journal of Neuroinflammation. 22(1). 213–213.
2.
Li, Yafei, Shuoshuo Wang, Guoli Li, et al.. (2024). The RNA‐binding protein RBMS3 inhibits the progression of colon cancer by regulating the stability of LIMS1 mRNA. Cancer Medicine. 13(7). e7129–e7129. 5 indexed citations
3.
Xu, Chang, Mingjie Zhang, Cheng Lyu, et al.. (2024). Integrated single-cell transcriptome and TCR profiles of hepatocellular carcinoma highlight the convergence on interferon signaling during immunotherapy. Journal for ImmunoTherapy of Cancer. 12(11). e010534–e010534. 2 indexed citations
5.
Liu, Miao, Yu Liu, Shuang Zhao, et al.. (2021). Clinical Significance of Screening Differential Metabolites in Ovarian Cancer Tissue and Ascites by LC/MS. Frontiers in Pharmacology. 12. 701487–701487. 12 indexed citations
6.
Wang, Yiru, Yunduo Liu, Yue Guan, et al.. (2020). Integrated analysis of immune-related genes in endometrial carcinoma. Cancer Cell International. 20(1). 477–477. 10 indexed citations
7.
Tang, Jing, Yuguang Ye, Yu Liu, et al.. (2019). Inhibition LC3B can increase chemosensitivity of ovarian cancer cells. Cancer Cell International. 19(1). 199–199. 23 indexed citations
8.
Liu, Yu, Jing Tang, Duanyang Liu, et al.. (2018). Increased autophagy in EOC re-ascites cells can inhibit cell death and promote drug resistance. Cell Death and Disease. 9(4). 419–419. 17 indexed citations
9.
Liu, Duanyang, Dan Kong, Jing Li, et al.. (2018). HE4 level in ascites may assess the ovarian cancer chemotherapeutic effect. Journal of Ovarian Research. 11(1). 47–47. 10 indexed citations
10.
Xu, Ye, Jiawei Yu, Tianbo Liu, et al.. (2016). Loss of FBXW7 is related to the susceptibility and poor prognosis of cervical squamous carcinoma. Biomarkers. 21(4). 379–385. 13 indexed citations
11.
Zhang, Lei, Dan Kong, Hongxue Meng, et al.. (2016). Plasma Gelsolin Promotes Proliferation of Mesangial Cell in IgA Nephropathy. Cellular Physiology and Biochemistry. 40(6). 1473–1486. 8 indexed citations
12.
Kong, Dan, Jing Li, Bairong Xia, et al.. (2015). The effect of SCF and ouabain on small intestinal motility dysfunction induced by gastric cancer peritoneal metastasis. Clinical & Experimental Metastasis. 32(3). 267–277. 10 indexed citations
13.
Zhao, Ran, Yiqi Wu, Tianzhen Wang, et al.. (2015). Elevated Src expression associated with hepatocellular carcinoma metastasis in northern Chinese patients. Oncology Letters. 10(5). 3026–3034. 20 indexed citations
14.
Wang, Tianzhen, Yinji Jin, Ran Zhao, et al.. (2014). High load hepatitis B virus replication inhibits hepatocellular carcinoma cell metastasis through regulation of epithelial–mesenchymal transition. International Journal of Infectious Diseases. 20. 37–41. 8 indexed citations
15.
Kong, Dan, Ran Liu, Jianjun Jiang, et al.. (2013). Individual and combined developmental toxicity assessment of bisphenol A and genistein using the embryonic stem cell test in vitro. Food and Chemical Toxicology. 60. 497–505. 26 indexed citations
16.
Kong, Dan, Di Wu, Tianzhen Wang, et al.. (2013). Detection of viral antigens in renal tissue of glomerulonephritis patients without serological evidence of hepatitis B virus and hepatitis C virus infection. International Journal of Infectious Diseases. 17(7). e535–e538. 27 indexed citations
19.
Wang, Tianzhen, Ran Zhao, Yiqi Wu, et al.. (2011). Hepatitis B virus induces G1 phase arrest by regulating cell cycle genes in HepG2.2.15 cells. Virology Journal. 8(1). 231–231. 26 indexed citations
20.
Tong, Dandan, Ming Li, Dan Kong, et al.. (2009). RUNX3 Inhibits Cell Proliferation and Induces Apoptosis by TGF-β-Dependent and -Independent Mechanisms in Human Colon Carcinoma Cells. Pathobiology. 76(4). 163–169. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026